Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.62 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.59 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425590 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL28996904 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL168065 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| Dodecane SCHEMBL1325927 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL1237976 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL23854065 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL165538 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL17646228 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL1512830 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL4962689 | 1.00 | GRIK1 (0.62) | GRIK1GRIK2SLC1A2SLC1A1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3075401-B1 | PRESERVATION FOR COSMETIC, TOILETRY AND PHARMACEUTICAL COMPOSITIONS | INOLEX INVESTMENT CORP (US) | 2024-04-03 | — | — | EP | claimed |
| CN-117137814-A | Cosmetic composition with affinity to skin microbiome | 株式会社LG生活健康 | 2023-12-01 | — | — | CN | claimed |
| CN-111885993-B | Liposomal composition comprising cultured root extract of mountain ginseng and composition for personal beauty or personal care containing the same | 株式会社韩国化妆品制造 | 2023-04-04 | — | — | CN | claimed |
| EP-4114182-A1 | METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS | Apeel Technology, Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| EP-1809243-B2 | AEROSOL SUSPENSION FORMULATIONS CONTAINING TG 227 EA AS A PROPELLANT | BOEHRINGER INGELHEIM INT (DE) | 2022-06-08 | — | — | EP | claimed |
| US-20210298298-A1 | METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS | APEEL TECHNOLOGY, INC. | 2021-09-30 | — | — | US | claimed |
| CN-113316606-A | Method for preparing superabsorbent polymer | UPL有限公司 | 2021-08-27 | — | — | CN | claimed |
| WO-2021058158-A1 | PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTER | HENKEL AG & CO. KGAA (DE) | 2021-04-01 | — | — | WO | claimed |
| EP-3006045-B3 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs | CYPRUMED GMBH (AT) | 2021-03-17 | — | — | EP | claimed |
| EP-2988731-B1 | COMPOSITION FOR USE IN REDUCING SCAB FORMATION AND PROMOTING HEALING | BIOGLAN AB (SE) | 2021-02-17 | — | — | EP | claimed |
| EP-0754028-A1 | NOVEL DEODORISING AND ANTI-MICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPICAL PREPARATIONS | Beiersdorf Aktiengesellschaft (DE) | 1997-01-22 | — | — | EP | claimed |
| EP-0483812-B1 | Prevention of toxin production using absorbent products | MCNEIL PPC INC (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0705605-A2 | Use of fatty acid esters against superinfections | Beiersdorf Aktiengesellschaft (DE) | 1996-04-10 | — | — | EP | claimed |
| WO-1995026708-A2 | NOVEL DEODORISING AND ANTI-MICROBIAL COMPOSITIONS FOR USE IN COSMETIC OR TOPICAL PREPARATIONS | BEIERSDORF AG (DE) | 1995-10-12 | — | — | WO | claimed |
| EP-0487524-B1 | METHOD AND APPARATUS FOR DETERMINING NON-TRIGLYCERIDES IN OILS | LIBRA LAB INC (US) | 1995-05-10 | — | — | EP | claimed |
| EP-0451949-B1 | Transparent stick compositions | UNILEVER PLC (GB) | 1994-09-14 | — | — | EP | claimed |
| EP-0402407-B1 | TRANSDERMAL ESTRADIOL DELIVERY SYSTEM | RIKER LABORATORIES INC (US) | 1994-08-03 | — | — | EP | claimed |
| EP-0596284-A2 | Antimycotic cosmetic and dermatological compositions containing fatty acid esters | Beiersdorf Aktiengesellschaft (DE) | 1994-05-11 | — | — | EP | claimed |
| EP-0376534-B1 | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine | RIKER LABORATORIES INC (US) | 1993-12-15 | — | — | EP | claimed |
| EP-0219539-B1 | TRANSDERMAL NITROGLYCERIN DELIVERY SYSTEM | RIKER LABORATORIES, INCORPORATED (US) | 1992-06-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210298298-A1 | METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS | MGLL, AGL, GK | GRIK1 1110/4885GRIK2 1070/4885SLC1A2 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.